R&D Systems Human Siglec-2/CD22 Fc Chimera Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Manufacturer: R&D Systems 1968SL050
DescriptionThe Recombinant Human Siglec-2/CD22 Fc Chimera Protein is derived from NS0. The Recombinant Human Siglec-2/CD22 Fc Chimera Protein has been validated for the following applications: Bioactivity.
This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|101.9 kDa (monomer)|
|95%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Mouse myeloma cell line,NS0-derived human Siglec-2/CD22 protein, (N-terminus) Human Siglec-2 (Asp20-Arg687) Accession &Num; CAA42006 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|Siglec-2/CD22 Fc Chimera|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|